Pedro Perez on Deep Vein Thrombosis in 2026: Getting the First Decisions Right
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Deep Vein Thrombosis in 2026: Getting the First Decisions Right
Even with major advances in treatment, outcomes in deep vein thrombosis (DVT) still depend heavily on early decisions.
Many preventable complications—such as pulmonary embolism, bleeding, recurrence, and long-term leg symptoms—don’t happen because we lack treatment options.
They happen when the early steps aren’t clear or consistent.
A few principles that still matter:
• Assess risk before jumping to testing
• Use blood tests thoughtfully, not automatically
• Imaging should be targeted, not excessive
• Treatment plans should be intentional and reassessed
• The first few months after diagnosis are critical
When DVT is approached in a structured, step-by-step way, outcomes improve and unnecessary interventions can often be avoided.
Clear decision-making early on remains one of the most powerful tools in managing DVT—now and in the years ahead.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!